Literature DB >> 22042931

Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.

Jane A Leopold1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22042931      PMCID： PMC3684970          DOI： 10.1161/CIRCULATIONAHA.111.067918

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  Circulating biomarkers of collagen metabolism in cardiac diseases.

Authors:  Begoña López; Arantxa González; Javier Díez
Journal:  Circulation       Date:  2010-04-13       Impact factor: 29.690

2.  Aldosterone receptor antagonists: effective but often forgotten.

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

3.  Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.

Authors:  James E Udelson; Arthur M Feldman; Barry Greenberg; Bertram Pitt; Robin Mukherjee; Henry A Solomon; Marvin A Konstam
Journal:  Circ Heart Fail       Date:  2010-03-18       Impact factor: 8.790

4.  Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".

Authors:  Selma F Mohammed; Tomohito Ohtani; Josef Korinek; Carolyn S P Lam; Katarina Larsen; Robert D Simari; Maria L Valencik; John C Burnett; Margaret M Redfield
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

5.  Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.

Authors:  Wafae Iraqi; Patrick Rossignol; Michael Angioi; Renaud Fay; Josette Nuée; Jean Marie Ketelslegers; John Vincent; Bertram Pitt; Faiez Zannad
Journal:  Circulation       Date:  2009-04-27       Impact factor: 29.690

6.  Significant changes in mitral valve leaflet matrix composition and turnover with tachycardia-induced cardiomyopathy.

Authors:  Elizabeth H Stephens; Tomasz A Timek; George T Daughters; Joyce J Kuo; Aaron M Patton; L Scott Baggett; Neil B Ingels; D Craig Miller; K Jane Grande-Allen
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

7.  Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study.

Authors:  Wolfgang Lieb; Martin G Larson; Emelia J Benjamin; Xiaoyan Yin; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Thomas J Wang; Joseph A Vita; Daniel Levy; Ramachandran S Vasan; Gary F Mitchell
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

8.  Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Authors:  Renate B Schnabel; Martin G Larson; Jennifer F Yamamoto; Lisa M Sullivan; Michael J Pencina; James B Meigs; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Philip A Wolf; Jared W Magnani; Patrick T Ellinor; Thomas J Wang; Daniel Levy; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

Review 9.  Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?

Authors:  Shweta Bansal; JoAnn Lindenfeld; Robert W Schrier
Journal:  Circ Heart Fail       Date:  2009-07       Impact factor: 8.790

10.  Relations of biomarkers representing distinct biological pathways to left ventricular geometry.

Authors:  Raghava S Velagaleti; Philimon Gona; Daniel Levy; Jayashri Aragam; Martin G Larson; Geoffrey H Tofler; Wolfgang Lieb; Thomas J Wang; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690
View more
  11 in total

1.  Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.

Authors:  Eve Maubec; Cédric Laouénan; Lydia Deschamps; Van Tuan Nguyen; Isabelle Scheer-Senyarich; Anne-Catherine Wackenheim-Jacobs; Maud Steff; Stéphanie Duhamel; Sarah Tubiana; Nesrine Brahimi; Stéphanie Leclerc-Mercier; Béatrice Crickx; Claudine Perret; Selim Aractingi; Brigitte Escoubet; Xavier Duval; Philippe Arnaud; Frederic Jaisser; France Mentré; Nicolette Farman
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

2.  Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.

Authors:  A Gupta; C G Schiros; K K Gaddam; I Aban; T S Denney; S G Lloyd; S Oparil; L J Dell'Italia; D A Calhoun; H Gupta
Journal:  J Hum Hypertens       Date:  2014-09-18       Impact factor: 3.012

3.  Cyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male mice.

Authors:  Sachindra Raj Joshi; Anand Lakhkar; Vidhi Dhagia; Ariadne L Zias; Vasiliki Soldatos; Kaori Oshima; Houli Jiang; Katherine Gotlinger; Jorge H Capdevila; Michal L Schwartzman; Ivan F McMurtry; Sachin A Gupte
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

Review 4.  The past, present and future of renin-angiotensin aldosterone system inhibition.

Authors:  Robert J Mentz; George L Bakris; Bernard Waeber; John J V McMurray; Mihai Gheorghiade; Luis M Ruilope; Aldo P Maggioni; Karl Swedberg; Ileana L Piña; Mona Fiuzat; Christopher M O'Connor; Faiez Zannad; Bertram Pitt
Journal:  Int J Cardiol       Date:  2012-10-31       Impact factor: 4.164

5.  Effect of fibulin-5 on aldosterone-induced apoptosis in human ascending aortic smooth muscle cells.

Authors:  Yongji Yan; Xujie Liu; Xuanchen Li; Xuan Zhou; Chaozhi Yang; Jintao Tian; Jun Pu; Xiaoqun Niu
Journal:  Exp Ther Med       Date:  2021-06-23       Impact factor: 2.447

6.  Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction.

Authors:  Yan Liu; Kunshen Liu
Journal:  Exp Ther Med       Date:  2014-06-18       Impact factor: 2.447

7.  Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism.

Authors:  Hiroko Ogata; Yuto Yamazaki; Yuta Tezuka; Xin Gao; Kei Omata; Yoshikiyo Ono; Yoshihide Kawasaki; Tomoaki Tanaka; Hidekazu Nagano; Norio Wada; Yutaka Oki; Akira Ikeya; Kenji Oki; Yoshiyu Takeda; Mitsuhiro Kometani; Kazunori Kageyama; Ken Terui; Celso E Gomez-Sanchez; Shujun Liu; Ryo Morimoto; Kensuke Joh; Hiroshi Sato; Mariko Miyazaki; Akihiro Ito; Yoichi Arai; Yasuhiro Nakamura; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  Hypertension       Date:  2021-06-14       Impact factor: 9.897

Review 8.  Should there be sex-specific criteria for the diagnosis and treatment of heart failure?

Authors:  Lawrence E Greiten; Sara J Holditch; Shivaram Poigai Arunachalam; Virginia M Miller
Journal:  J Cardiovasc Transl Res       Date:  2013-11-09       Impact factor: 4.132

Review 9.  Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives.

Authors:  Enrico Vizzardi; Valentina Regazzoni; Giorgio Caretta; Mara Gavazzoni; Edoardo Sciatti; Ivano Bonadei; Eleftheria Trichaki; Riccardo Raddino; Marco Metra
Journal:  Int J Cardiol Heart Vessel       Date:  2014-03-19

Review 10.  Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging.

Authors:  Stefania Gorini; Seung Kyum Kim; Marco Infante; Caterina Mammi; Sandro La Vignera; Andrea Fabbri; Iris Z Jaffe; Massimiliano Caprio
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-23       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.